** Shares of pharmaceutical firm IDT Australia IDT.AX jump
as much as 7.9% to A$0.068, their biggest intra-day pct gain
since May 31
** Co says Q4 FY23 revenue rose 200% to A$2.4 million ($1.60
million) vs Q1 FY23
** Sees positive outlook across all three business verticals
** Says well-positioned for revenue growth in FY24
** More than 328,200 shares change hands as compared with
the 30-day average volume of ~352,100 shares
** Stock down 21.3% this year as of last close, vs a 0.1%
increase in the benchmark S&P/ASX 200 index .AXJO
($1 = 1.4966 Australian dollars)
(Reporting by Roushni Nair in Bengaluru)
((Roushni.Nair@thomsonreuters.com;))